Since TEAD is the major transcription factor mediating YAP/TAZ oncogenic functions, it has been proposed that direct disruption of the YAP/TAZ–TEAD interaction would be an attractive strategy to restrain the transcriptional outputs of YAP/TAZ and the Hippo pathway for cancer therapy [13,15,16,17]. Here, YAP1 is linked to cancer.